ATBPF News Alert Antibe Therapeutics (ATBPF) 0.3984 12/25/2014

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Antibe Therapeutics (ATBPF) 0.3984 $ATBPF

Antibe Therapeutics Announces Appointment of Canadian Rheumatologist J. Carter Thorne to Its Clinical Advisory Board
Business Wire - Thu Dec 18, 6:45AM CST
Antibe Therapeutics Inc. ("Antibe" or the "Corporation" (TSXV:ATE; OTCQX:ATBPF) is pleased to announce the expansion of its Clinical Advisory Board with the appointment of Canadian rheumatologist J. Carter Thorne, MD, FRCP(C), FACP, Chief of the Division of Rheumatology and Director of The Arthritis Program at Southlake Regional Health Centre in Newmarket, Canada.
ATE.VN: 0.500 (+0.050)

Antibe Therapeutics Announces Appointment of US-Based Investor Relations Consultant
Business Wire - Tue Dec 16, 6:45AM CST
Antibe Therapeutics Inc. ("Antibe" or the "Corporation" (TSXV: ATE, OTCQX: ATBPF) today announced that they have, subject to approval by securities regulators, entered into an Investor Relations Consulting Agreement with Stonegate Capital Partners Inc. ("Stonegate" based in Dallas, Texas. Under the terms of the agreement Stonegate will receive a monthly fee of $4,000 for a minimum of 6 months and will be granted 24,000 options. Such options will vest quarterly starting on the date of the grant, will be exercisable at a price of $0.52, and will expire October 31, 2017.
ATE.VN: 0.500 (+0.050)

Antibe Therapeutics Reports Q2 2015 Interim Financial and Operating Results
Business Wire - Fri Nov 28, 6:45AM CST
Antibe Therapeutics Inc. ("Antibe" or the "Corporation" (TSXV: ATE) filed its financial and operating results today for its fiscal quarter ended September 30, 2014.
ATE.VN: 0.500 (+0.050)

Antibe Therapeutics Provides Update on Its Acute Pain Drug ATB-352
Business Wire - Tue Nov 25, 6:30AM CST
Antibe Therapeutics Inc. ("Antibe" or the "Corporation" (TSXV: ATE; OTCQX: ATBPF) is pleased to report results from animal proof-of-concept studies on ATB-352, which is the second drug in the Company's pipeline, as described in the CEO Letter of April 2014. These studies have demonstrated that ATB-352 potently inhibits the production of pain-signalling chemicals (prostaglandins) in rats, but does not produce significant ulceration in the stomach or intestine, even at very high doses. In the same study, administration of the painkiller ketoprofen caused severe and extensive intestinal ulceration and bleeding.
ATE.VN: 0.500 (+0.050)

Antibe Therapeutics Completes Single Ascending Dose Portion of ATB-346 Phase I Program
Business Wire - Mon Oct 06, 6:30AM CDT
Antibe Therapeutics Inc. ("Antibe" or the "Corporation" (TSXV:ATE; OTCQX:ATBPF) is pleased to report that the pre-scheduled single ascending dose portion of its Phase I program has been completed and has reached its primary objectives of safety and tolerability of ATB-346, up to the maximum dose tested (1500 mg). The results of this portion of the Phase I program have met the corporation's expectations based on extensive pre-clinical studies, and support the continuation of the Phase I program into the multiple ascending dose and food-effect portions, both of which are underway and are expected to be completed by January 2015.
ATE.VN: 0.500 (+0.050)

Antibe Therapeutics Reports on Results of AGM Voting
Business Wire - Fri Oct 03, 6:30AM CDT
Antibe Therapeutics Inc. ("Antibe" or the "Corporation" (TSXV:ATE; OTCQX:ATBPF) is pleased to report the results of the voting on the matters submitted to the annual meeting of shareholders of the Corporation held on October 1, 2014.
ATE.VN: 0.500 (+0.050)

Merriman Capital Announces Sponsorship of Antibe Therapeutics Inc. on OTCQX
Thomson Reuters ONE - Mon Sep 15, 8:01AM CDT
SAN FRANCISCO - September 15, 2014 - Merriman Capital, Inc., a wholly owned subsidiary of Merriman Holdings, Inc. (OTCQX: MERR), announced today that it will serve as the Principal American Liaison (PAL) for Antibe Therapeutics Inc. (OTCQX: ATBPF) ("Antibe Therapeutics" as it begins trading on OTCQX(R). The OTC announced today that the Antibe Therapeutics is now trading on the OTC market's highest tier, the OTCQX.

Antibe Therapeutics Commences Trading on the US OTCQX Marketplace
Business Wire - Mon Sep 15, 6:30AM CDT
Antibe Therapeutics Inc. ("Antibe" or the "Corporation" (TSXV: ATE, OTCQX: ATBPF) is pleased to announce that, as of today, common shares of the Corporation began trading in the United States on the OTCQX exchange under the ticker symbol "ATBPF". Antibe's common shares will continue to trade on the TSX Venture Exchange under the symbol "ATE".
ATE.VN: 0.500 (+0.050)

OTC Markets Group Welcomes Antibe Therapeutics to OTCQX®
PR Newswire - Mon Sep 15, 6:00AM CDT
OTC Markets Group Inc. (OTCQX: OTCM), operator of Open, Transparent and Connected financial marketplaces, today announced Antibe Therapeutics Inc. (TSX-V: ATE; OTCQX: ATBPF), a human drug development company, has qualified to trade on OTCQX®, the best marketplace.
ATE.VN: 0.500 (+0.050)

Antibe Therapeutics' Founder Leads Study Identifying a Novel Mechanism for Treating Inflammatory Bowel Disease
Business Wire - Fri Sep 05, 6:30AM CDT
Antibe Therapeutics Inc.'s Founder and Chief Scientific Officer, Dr. John Wallace, is the senior author of an article published this week in the prestigious scientific journal Proceedings of the National Academy of Science USA describing research that may lead to a significant improvement in the treatment of Crohn's Disease and Ulcerative Colitis, collectively known as "inflammatory bowel disease" (IBD).
ATE.VN: 0.500 (+0.050)




Scroll down for more posts ▼

Top 10 Most Recent News Articles

S&P Global's December 8 Talk Puts Guidance in Focus

Updated Category News Views 54

A 35-minute fireside chat can be a whole lot of nothing, or it can leave a useful breadcrumb trail for shareholders willing to listen closely. S&P Global has put December 8, 2026 on the calendar, when Chief Executive Officer Martina Cheung is scheduled to appear at Goldman Sachs' 2026 Financial Services Conference in New York. Her slot runs from 5:00 p.m. to 5:35 p.m....

Continue Reading
California Rideshare Data Exposes an Insurance Gap

Updated Category News Views 52

Three California counties carried an outsized share of rideshare traffic, and the insurance fine print is where this story gets uncomfortable. A review by Mendez & Sanchez says Los Angeles, San Francisco, and San Diego counties accounted for nearly two-thirds of statewide rideshare trips between September 2019 and August 2020. That is an old snapshot, sure, but it points...

Continue Reading
Nevada’s Space Academy Bid Has Assets, Not a Win Yet

Updated Category News Views 29

Desert acreage and a moon-landing backstory make for a handsome pitch, but Nevada is still standing at the starting line. The state has submitted its official response to NASA’s Request for Information for a proposed United States Space Academy, and the new promotional video is meant to show why the Silver State belongs in the conversation. Fair enough. There is real...

Continue Reading
Mars Sets $2 Billion Debt Tender With Kellanova Notes

Updated Category News Views 124

A two-billion-dollar vacuum cleaner just switched on inside Mars’s debt stack, and the timing is anything but casual. On November 20, Mars fixed the pricing for cash tender offers spanning selected Mars and Kellanova senior notes, with holders facing a 5:00 p.m. New York deadline that same day. This is the kind of filing that looks like bond-market plumbing until you...

Continue Reading
TEN Holdings Raises $1.0 Million as Dilution Looms

Updated Category News Views 66

A Small Raise With a Loud Message Nothing says “we need room to breathe” quite like selling 1,492,500 new shares for $0.67 apiece. TEN Holdings closed a roughly $1.0 million gross equity offering on November 20, 2026, and investors in NASDAQ:XHLD ought to look at this for what it is: a modest cash infusion that comes with immediate dilution. The company gets capital;...

Continue Reading
Sidus Gains Argotec Order, but Investors Need the Math

Updated Category News Views 149

A Real Customer Signal, Minus the Revenue Figure An updated image is the least interesting detail in this release. Sidus Space has landed a purchase order from Argotec Group to manufacture cable assemblies for the HAWK satellite platform, with delivery expected in the first quarter of 2027. That is a legitimate operational win for NASDAQ:SIDU. It brings in a new...

Continue Reading
Saturn and Tileward Put GPU Memory Back to Work Now

Updated Category News Views 49

GPU memory is the tollbooth nobody notices until the whole AI highway backs up. Saturn Cloud’s new partnership with Tileward goes straight at that constraint: use compressed open-model weights, free memory on hardware already installed, and turn that reclaimed capacity into more tokens that an operator can actually sell. It is not glamorous. It may be one of the more...

Continue Reading
Midterm Voters Put Cost Relief Ahead of Washington Wars

Updated Category News Views 78

Gas pumps and medical bills have a way of humiliating every grand political slogan ever printed. Seven Letter Insight's latest post-election survey says confirmed 2026 midterm voters want the 120th Congress to deal with costs first, particularly gas prices, health care, restoring health care tax credits and energy bills. That is not a glamorous mandate. It is, however,...

Continue Reading
Delayed Remodels Can Quietly Drain Your Home's Value

Updated Category News Views 73

A pinhole leak has a nasty talent for becoming a demolition budget. That is the plain lesson in Jason Marks' discussion of delayed remodeling for homeowners in Kernersville, North Carolina. People tend to see a worn bathroom, tired kitchen, or drafty window and think, “Not pretty, but it can wait.” Sometimes it can. Sometimes that little delay lets water, rot,...

Continue Reading
Tampa General's Food Bet Earns a 2026 Innovation Award

Updated Category News Views 41

Hospital meals have long been the punchline nobody bothered to fix, which is why Tampa General Hospital's latest recognition deserves a closer look. The not-for-profit academic health system was named the 2026 Inno Pick by the Tampa Bay Business Journal for its Food as Medicine initiative, its fifth straight year landing among the publication's Inno Award honorees. Awards...

Continue Reading

Top 5 Most Recently Viewed Articles

PLAY Airlines Achieves Record Load Factor and Revenue Growth

Updated Category News Views 271

PLAY Airlines Reports Record-Breaking Load Factor for November PLAY Airlines has announced that it carried an impressive 99,393 passengers in the month of November, showcasing its operational efficiency and strategic adaptations. Although this is a decrease from the 107,236 passengers flown in the same month in the previous year, this is largely attributed to a 17%...

Continue Reading
Exciting Drilling Results from U.S. GoldMining's Whistler Project

Updated Category News Views 101

U.S. GoldMining Reports Drilling Success at Whistler Project U.S. GoldMining Inc. (NASDAQ: USGO) has recently revealed initial results from its drilling activities at the Whistler Gold-Copper Project. This exciting announcement highlights the results from the first two diamond drill holes of the 2024 program. The drilling aims to expand on the previously identified...

Continue Reading
Trados Studio 2026: AI Innovations Elevate Translation

Updated Category News Views 82

Revolutionizing Translation: The Trados Studio 2026 Release It's barely out of the gate, and Trados Studio 2026 is already stirring the pot in the translation world. RWS, the company behind this game-changer, has loaded it with some serious tech muscle. Imagine turning a sluggish operation into a nimble powerhouse—well, that's the promise with the newest Trados Studio...

Continue Reading
Financial Institutions Innovate with Alternative Credit Data Insights

Updated Category News Views 210

Financial Institutions Innovate with Alternative Credit Data Insights Forty percent of financial institutions report rising delinquencies amid growing economic pressure. Recently, LexisNexis Risk Solutions shared the findings of its groundbreaking study on global consumer lending confidence, illustrating significant changes in how financial institutions assess consumer...

Continue Reading
Careviso Elevates Healthcare Access with Innovative COB Feature

Updated Category News Views 166

Careviso Unveils New Coordination of Benefits Feature Careviso, a leader in healthcare patient access technology, has introduced an innovative Coordination of Benefits (COB) feature in its seeQer platform and API. This feature aims to revolutionize the way healthcare organizations process multiple insurance coverages, ensuring that patients receive the most accurate...

Continue Reading